|
⚲
|
| Keyboard |
| Broidrick Amy S
✚
|
|
|---|---|
| CIK # | 0001822917 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001822917] | |
| 4 | [0001822917] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ritter Pharmaceuticals Inc | |
| Broidrick Amy S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2022-07-11 | Grant | 130,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2022-06-14 | Buy | 30,000 | $0.62 | 18,600 |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2021-12-08 | Grant | 300,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2021-04-26 | Buy | 4,500 | $2.03 | 9,135 |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-12-07 | Grant | 150,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-08-27 | Grant | 50,000 | $0.00 |